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Abstract
In vaccine development, the temporal profiles of relative abundance of subtypes of immune cells
(T-cells) is key to understanding vaccine efficacy. Complex and expensive experimental studies generate
very sparse time series data on this immune response. Fitting multi-parameter dynamic models of the im-
mune response dynamics– central to evaluating mechanisms underlying vaccine efficacy– is challenged
by data sparsity. The research reported here addresses this challenge. For HIV/SIV vaccine studies
in macaques, we: (a) introduce novel dynamic models of progression of cellular populations over time
with relevant, time-delayed components reflecting the vaccine response; (b) define an effective Bayesian
model fitting strategy that couples Markov chain Monte Carlo (MCMC) with Approximate Bayesian Com-
putation (ABC)– building on the complementary strengths of the two approaches, neither of which is
effective alone; (c) explore questions of information content in the sparse time series for each of the
model parameters, linking into experimental design and model simplification for future experiments;
and (d) develop, apply and compare the analysis with samples from a recent HIV/SIV experiment, with
novel insights and conclusions about the progressive response to the vaccine, and how this varies across
subjects.
AMS subject classifications: 62P10, 62M99
Keywords and Phrases: Approximate Bayesian Computation (ABC); Bayesian Inference; Dynamic Models;
Immunology; Learnability of Parameters; Markov chain Monte Carlo (MCMC); ODE Models; Sparse
Data; Time Delays; Vaccine Design
1 Introduction
In vaccine design and development, experiments in non-human primates (NHPs) are necessary preludes
to human clinical trials. Our focus here is on a key case in point, that of new HIV/SIV immunization
strategies. While becoming more prevalent, NHP vaccination experiments are expensive and complex,
so typically generate small sample sizes and a limited number of longitudinal observations [9, 11, 14].
Mathematical modeling of the immune response dynamics to vaccination can provide insight into the
mechanisms underlying vaccine efficacy and help predict the likely human response to the immunization
strategy [5, 8, 20, 27]. To capture the complexity of the immune response, such mathematical models are
often represented using coupled systems of nonlinear ordinary differential equations (ODEs). We are then
∗Google Youtube. bonassi@gmail.com
†Duke University Medical Center. cliburn.chan@duke.edu
‡Duke University. mw@stat.duke.edu
§Research partly supported by a grant from the National Science Foundation [DMS-1106516] and grants from the National
Institutes of Heath [NIH P50-GM081883 and 5P30 AI064518]. Any opinions, findings and conclusions or recommendations
expressed in this work are those of the authors and do not necessarily reflect the views of the NSF or NIH.
1
ar
X
iv
:1
60
6.
08
75
9v
1 
 [s
tat
.M
E]
  2
8 J
un
 20
16
faced with the challenges of model fitting with multiple model parameters on very sparse data. There is
also a key interest in variability in these characterizing parameters across subjects, since NHPs come from
outbred populations so that the immune response is likely to vary across individuals.
We address these general questions in a specific vaccine design study, involving evaluation of efficacy
of a replicating Adenovirus Simian Immunodeficiency Virus (SIV) vector [17] introduced via different
mucosal routes in a collection of macaques [16]. We summarize the context and experiment, and address
questions of dynamic modeling of the vaccine response of each macaque. Beginning with coupled systems
of ODEs for the vaccine response, we discretize to define a class of non-linear, discrete-time state-space
models for the data defined by cell subtype frequencies. This model framework builds on prior models in
the field, while going much further with innovations in time-delay modeling and discretization. We also
describe a mapping of model parameters to dimensionless parameters for fundamental characterization and
comparison across subjects.
Standard computational methods for model fitting– analytic approximations coupled with either Markov
chain Monte Carlo [15, 25], or sequential Monte Carlo including Approximate Bayesian Computation
(ABC) [e.g., 2, 13, 18, 21]– are fundamentally challenged due to non-linearities and data sparsity. After
exploring such approaches, we have defined with a creative coupling of MCMC and ABC methods that
builds on the complementary strengths of the two approaches.
In any modeling context where data is very sparse, questions should arise about which of the param-
eters are informed upon, at all, and the extent of the information content of the data for each parameter.
We discuss and investigate this here, evaluating the prior-to-posterior mapping via entropy and variance
to quantify “learnability” of parameters from the sparse time series data. This is useful in interpreting
posterior summaries and comparing across experimental subjects, and aids thinking about potential model
simplifications and design for future experiments.
Application to the macaque data is discussed and evaluated in the context of the goals of the experi-
ment. The precision of inferences on temporal profiles in the immune response is highlighted along with
these questions of model specification and potential parameter redundancy. We see real differences be-
tween some of the response-characterizing parameters across individuals, and strong evidence from the
overall study that there is a significant time delay in memory T-cells responding to the vaccine interven-
tions. These broad summaries alone represent novel and meaningful findings in the HIV/SIV vaccine
response field. Moreover, the analyses suggest that the dynamics of the immune response depends on the
vaccination route,(i.e., the way in which the individual is vaccinated). This is a result that is not obvious
from inspection of the time series data alone, and is a novel and potential important finding in its own
right, suggesting the need– and likely design principles– for further experiments.
2 Basics of Vaccine Biology and Experiment
We performed a longitudinal study to compare the mucosal immune response when a prime-boost vac-
cine using replication-competent viral vector was given via different routes. Replication-competent Ade-
novirus (Ad5) with recombinant Simian Immunodeficiency Virus (SIV) Gag genes (Ad5hr-SIVgag) and a
GFP marker for tracking was administered to Indian Rhesus macaques via intra-nasal/intra-tracheal, intra-
vaginal and intra-rectal routes. The macaques were vaccinated twice with the replicating Ad recombinants
(encoding SIV env/rev and gag, plus Ad-GFP) at weeks 0 and 12, and boosted with SIV envelope protein
plus adjuvant at weeks 24 and 36 of the study. Relative abundance of functionally and maturationaly
different T-cell subtypes were estimated from flow cytometric assays [e.g., 3, 4, 12] on samples from gut
mucosa and peripheral blood. A small number of the macaques also had 2-4 measurments of GFP-labelled
Adnovirus infected macrophages in the gut mucosa. The summary estimates of cell subtype proportions at
each time point assayed provide the raw time series for each subject macaque. The key cellular subtype
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of interest here is the antigen-specific memory T-cells, and models will address its relation to the level of
abundance of the adenovirus-infected macrophages over time.
Replication-competent vectors continue to propagate themselves after vaccination and can sustain a
long-term immune response against the SIV genes encoded by the vector. Hence, we expect that the pop-
ulation size of the antigen-specific memory T-cell population is driven by the size of the replicating vector
population. Laboratory experiments suggested that the Adenovirus vector resided in host macrophages in
the gut mucosa. Our development of nonlinear models of the dynamics of the Ad5-infected macrophage
cells (using GFP-expression as a marker for Ad5 infection) in the rectal mucosa, coupled with the antigen-
specific memory T-cell response in the blood, aim at evaluating the effects of different vaccination routes
on the host response to a replication-competent Ad5 vector.
3 Conceptual/Qualitative Dynamic Modeling Framework
We begin with stylized thinking in terms of coupled ordinary differential equations (ODEs) to describe the
qualitative temporal changes in antigen and cellular concentrations in the immune system [e.g., 6]. This
is then extended in practicable statistical model development that involves discrete-time representations
of the conceptual differential equations systems, and time-delays in the immune response to vaccine inter-
vention. The discretized system of model equations is overlaid with stochastic components to realistically
reflect measurement error and unmodeled structure. The model includes noise and mechanistic rate pa-
rameters, initial conditions, and– critically– missing (latent) elements of the data time series on subsets of
cell frequencies.
3.1 Basic ODE Model
The motivating ODE model describes evolution in continuous time t of Adenovirus (Vt) and T-cell memory
(Mt) populations, following immunization of a subject with the adenovirus Ad5hr-SIVgag. With subject-
specific parameters, take
dVt
dt
= βVt
(
1− Vt
KV
)
,
dMt
dt
= αVt + ρVtMt
(
1− Mt
KM
)
.
(1)
The viral population is described by the first equation, a logistic growth form. In the second equation,
the first term has α = φN where N represents na¨ıve T-cells; the rate of generation of new na¨ıve cells that
recognize viral epitopes in the presence of a persistent Ad5 infection is fixed at α = φN , and the virus drives
their differentiation into into memory cells. The second term reflects density-dependent proliferation of
pre-existing memory cells. Finally, Vt and Mt have natural carrying capacities KV and KM , respectively.
3.2 Non-dimensionalization
The essential structure of the model, and a reduced number of parameters, arises via a map to the non-
dimensional version of the model. As will be seen later, this has a critical practical role in quantifying
learnability of model parameters. Let µ, ν and λ be scaling variables– positive, but otherwise arbitrary and
to be chosen– that define
vt = Vt/µ, mt = Mt/ν and s = t/λ.
Then, via the chain rule,
dvs
ds
=
λ
µ
dVt
dt
and
dms
ds
=
λ
ν
dMt
dt
.
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Substituting in equation (1) gives, after some algebra,
dvs
ds
= λβvs
(
1− vs
KV /µ
)
,
dms
ds
=
λαµ
ν
vs + λρµvsms
(
1− ms
KM/ν
)
.
Now choose to set µ = KV , ν = KM and λ = 1/β, so that equation (1) maps to the dimensionless model
dvs
ds
= vs(1− vs),
dms
ds
= ηvs + ψvsms(1−ms)
(2)
with η = λαµ/ν and ψ = λρµ. These dimensionless parameters (η, ψ) characterize the model; they aid in
exploring essential questions of information content of observed data, and in comparisons across subjects
in our later analyses.
4 Initial Discrete-time Stochastic Model
We have sparse observations on Vt,Mt at a small number of time points, and of course these are subject to
measurement errors, the nature of these errors being partly quantified in the flow cytometry assays. There
is also a need for stochastic elements in the time evolution of Vt,Mt to account for model misspecification,
i.e., structure not captured by the model. We now move to the practicable discretized form of the ODE
conceptual model and overlay these extensions.
Let xt = (Vt,Mt)′ be the latent state vector of virus and memory frequencies representing the true
underlying population densities for one individual at time t. We use reparametrizations δ = β/KV and
γ = ρ/KM to replace KV ,KM by new rate constants δ, γ. Note from equation (1) that this yields linear
forms in β, δ, α, ρ, γ and this simplifies analysis; we can then recover KV = β/δ,KM = γ/ρ as desired.
Discretize to time scale t = h, 2h, . . . , T with increment h > 0, and suppose observations are made only
at times t1 < t2 < · · · < tn. Directly via Euler discretization of equation (1), and allowing for measurement
errors and state evolution noise, we have
Vt = Vt−h + h(β − δVt−h)Vt−h + ωV ht
Mt = Mt−h + hαVt−h + h(ρVt−h − γVt−hMt−h)Mt−h + ωMht
(3)
over all t = h, . . . , T. The evolution noise ωht = (ωV ht, ωMht)′ represents stochastic noise in the state
evolution as well as the model misfit. We take this as zero-mean Gaussian with diagonal variance matrix
having variances (κ2V , κ
2
M ) that are now additional parameters.
Measurements are made at a set of times t1, . . . , tn. So we observe
yj = xtj + νj , j = 1, . . . , n, (4)
where measurement errors νj are zero-mean Gaussian with diagonal variance matrix having entries (σ2V , σ
2
M ),
additional parameters subject to prior information from flow cytometry assays. Sometimes only one of
Vt,Mt is measured at a particular tj . Let t ∈ OV and t ∈ OM be times measurements are made on Vt,Mt,
respectively. The time sets may or may not intersect. Theoretically, we can reflect this using measurement
error variances (σ2V /cV t, σ
2
M/cMt), where cV t = 1 but cMt → 0 when t ∈ OV but t /∈ OM , and so forth. This
results in minor technical changes to the analysis below.
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4.1 Extended Model: Incorporating Time Delays
The initial model form turns out to be unable to reflect a key feature of the data that relates to what in
retrospect is anticipated additional complexity in the immune response– that of time delays in the driving
of cellular differentiation following vaccine introduction. This is reflected in delay before appearance of
Ad5-infected macrophages in the gut mucosa. The basic model above is therefore extended to allow for
subject-specific time delays in the effects of the viral population level on the memory cells. Specifically,
equation (3) is extended to
Vt =
{
Vt−h + ωV ht, if t ≤ τV ,
Vt−h + h∂Vt−h + ωV ht, otherwise;
Mt =
{
Mt−h + ωMht, if t ≤ τV + τM ,
Mt−h + h∂Mt−h + ωMht, otherwise.
(5)
where
∂Vt−h = (β − δVt−h)Vt−h,
∂Mt−h = αVt−h + (ρVt−h − γVt−hMt−h)Mt−h.
Here τV is the time delay on the direct impact of vaccination on Vt, and τM is the additional delay before
Vt impacts on memory cells. The parameters are now
Θ = {β, δ, α, ρ, γ, V0, τV , τM , σ2V , σ2M , κ2V , κ2M} (6)
including the unknown, initial viral level V0, all noise, rate and delay parameters. We also note the implied
parameters of the dimensionless model are just λV = βτV and λM = βτM .
5 Bayesian Computation for Model Fitting
With observed data Y = {ytj , j = 1, . . . n}, we aim to explore the posterior p(Θ,X|Y) where X = {xt, t =
h, 2h, . . . , T} is the trajectory of latent states Vt,Mt over the time period. The model is a complicated,
non-linear dynamic model and standard computational methods of MCMC and sequential Monte Carlo,
including ABC, are notoriously challenged by the needs to define relevant proposal mechanisms, and high
rejection rates associated with long series of latent states. Recent approaches representing current research
frontiers focus heavily on biological systems applications [e.g., 2, 7, 10, 15, 26]. The sparsity of data in our
studies exacerbates the difficulties. MCMC is challenged by the nonlinearities and truncation to positive
states in the model. ABC methods are challenged by the high-dimensionality of the latent states and the
interest in relatively diffuse priors for model parameters, so that it is difficult to generate prior:model
simulations in the region of the sparse observed data. After detailed experimentation with these and other
approaches, including other sequential methods, we have identified a strategy of coupling MCMC with
adaptive ABC that draws on their complementary strengths. The two stages are:
(i) Use MCMC coupled with traditional analytic approximation (local linearization) of the model to
define an approximate posterior sample. Knowing that this will be biased in ways that are difficult to
assess,
(ii) Use this MCMC sample to define a proposal distribution for an efficient, adaptive ABC.
Step (i) is easy to implement and run to define a “ballpark” approximation to the posterior; step (ii)
is then ideal for ABC accept/reject methods, as approximate posterior samples are far more likely than
prior:model simulations to generate synthetic data close to the observed data. Reweighting corrects ABC
accepted samples to define the refined posterior approximation.
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5.1 First stage analysis: MCMC
At each MCMC step, model parameters are resampled from complete conditional posteriors given a cur-
rent set of latent states X. The conditional linearity of the model in rate parameters β, δ, α, ρ, γ and initial
V0; this means that uniform or normal priors yield truncated normal conditional posteriors. Then, in-
verse gamma priors are conditionally conjugate for the variances σ2V , σ
2
M , κ
2
V , κ
2
M . The resampling of delay
parameters τV , τM uses a Metropolis-Hastings random walk step.
Conditional on latest parameter samples, the full trajectory X is resampled from an approximation to
its posterior conditional on parameters. We use local linearization (extended Kalman filtering) for forward
filtering of the states, followed by backward sampling to generate X. The extended Kalman filter approach
[25, Section 13.2] sequentially updates conditional Gaussian distributions for the states over time, and at
each time uses the current mean of that Gaussian as a point of local linearization of the non-linear model
at that time. This maps to an approximating sequence of linear models, and standard forward filtering,
backward sampling (FFBS) [18, 25] to generate the full state trajectory applies.
Start with the exact non-linear model of evolution of the state xt = (Vt,Mt)′ in equation (5). This can
be cast as
zt = Ht(zt−h) zt−h + ξt (7)
with extended state vector zt, noise ξt and matrix Ht(zt−h) given by
zt = (Vt,Mt, Vt−1, Vt−2, . . . , Vt−τM+1)
′,
ξt = (ωV t, ωMt, 0, . . . , 0)
′,
Ht(zt−h) =

at 0 0 0 · · · 0 0
0 bt 0 0 · · · 0 ct
1 0 0 0 · · · 0 0
0 0 1 0 · · · 0 0
0 0 0 1 · · · 0 0
...
...
...
...
. . .
...
...
0 0 0 0 · · · 1 0

where
at =
{
1, if t ≤ τV ,
1 + β − δzt−h,1, if t > τV ;
{ct, bt} =
{
{0, 1}, if t ≤ τV + τM ,
{α, 1 + ρzt−h,τM+1 − γzt−h,2 zt−h,τM+1}, if t > τV + τM .
In linearized forward filtering, writemt−h for the current estimate of zt−h; this is the approximate posterior
mean conditional on data up to time t− h. Linearization adopts the model at time t as the dynamic linear
model obtained by replacing Ht(zt−h) in equation (7) with Ht(mt−h). This is performed sequentially over
t = h, 2h, . . . , T, saving relevant summaries at each step in order to then apply FFBS-based backward
sampling generate/resample the full trajectory X = {xh,x2h, . . . ,xT }.
5.2 Second stage analysis: ABC
MCMC is easily implemented but it is difficult to understand errors and biases induced by the approxima-
tions. The linearized model analysis does not impose positivity constraints on Vt,Mt, and other biases are
due to the inherent non-linearities. This motivates adjustments based on a second stage ABC approach.
The set of MCMC-based posterior samples for Θ,X are used to generate a proposal distribution for can-
didate draws in an ABC method. The ABC step refines the initial MCMC-based approximation, aiming to
correct biases; in complement, this drives ABC analysis with an already useful posterior approximation.
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Denote the observed data by Yo, and choose a discrepancy function δ(Y,Yo) measuring distance from
any candidate/synthetic observation set Y from Yo. Weighted ABC using a proposal distribution with p.d.f.
g(Θ) on the model parameters proceeds as follows:
• Sample a candidate parameter set Θ ∼ g(Θ);
• forward simulate the latent state X|Θ from the exact dynamic model and, given this X,
• generate synthetic data Y at the observation times t1, . . . , tn;
• if d(Y,Yo) <  for some small threshold  > 0, accept the candidate Θ; otherwise, try again.
• Once a large sample of accepted draws is achieved, resample with weights proportional to pi(Θ)/g(Θ)
where pi(Θ) is the prior p.d.f.
The result is a resampled set of parameters approximating p(Θ|Yo).
We define g(θ) as follows. For the rate parameters Λ = (β, δ, α, ρ, γ)– for which the posterior:prior
contrast is expected to be greatest– we use a truncated 5−dimensional Gaussian mixture distribution of
the form g(Λ) ∝ ∑j N(Λj , h2ΛSΛ)I(Λ∈A), where the Λj are the MCMC-based samples, hΛ is a bandwidth
multiplier, SΛ is the sample covariance matrix of MCMC draws, and A is the hypercube region formed by
the marginal ranges of each parameter in the MCMC sample. This follows [2] and [22–24], with details
there including bandwidth specification. The proposal distribution is completed as g(Θ) = g(Λ)g(Σ) where
g(Σ) is the product of the univariate priors on each element of Σ = {V0, τV , τM , σ2V , σ2M , κ2V , κ2M}.
6 Analysis: HIV/SIV Study on Indian Rhesus Macaques
Data on 8 subject macaques was generated from flow cytometric analysis of GFP-labeled macrophages (i.e.,
Ad5 infected) from rectal mucosa sampled at weeks 1, 13, 25 and 37, together with the concentrations of
gag-specific memory T-cells sampled at weeks 0, 4, 16, 28 and 40. Figure 1 shows the sparse time series of
concentrations of viral population (Vt) and memory cells (Mt) on 4 macaques. The remaining 4 data sets
are shown in the Supplementary Material. We perform separate analyses for each subject (macaque) and
explore comparisons of inferences across subjects.
6.1 Model Predictions of Trajectories
To appreciate the relevance of the discrete-time, stochastic model with delay effects, we show representa-
tive trajectories in Figure 2. These are simply model simulations of Vt,Mt using plug-in parameter values
that reflect the ranges we see in posteriors for some of the macaques, and is displayed here just to commu-
nicate that the model generates trajectories whose forms evidently match those of the data sets.
6.2 Priors
For the rate parameters (β, δ, α, ρ, γ) we start with independent U(0, 1) priors, then impose constraints so
that the carrying capacities Kv = β/δ and KM = ρ/γ are each less than 100%. Note that these are very
diffuse priors. Priors for the variance parameters are independent, scaled inverse chi-squared on 5 degrees
of freedom; their scale parameter are determined from analysis of data from other studies: sσ2V = 0.4,
sσ2M
= 0.08, sκ2V = 0.05, sκ2M = 0.01. For the time discretization, we take h = 1day and the priors for time
delays τV , τM are independent discrete uniforms on {1, . . . , 50}. The initial viral level V0 has a U(0, 0.5)
prior, and M0 is fixed at a value based on initial measurements for each macaque.
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Figure 1: Observed data Vt (blue) and Mt (red) for 4 of the 8 macaques (subject IDs 400, 401, 404, 405,
respectively).
Figure 2: Synthetic trajectories of Vt (blue) and Mt (red) from (V0,M0) = (0.5, 0.5), using model parame-
ters chosen to be consistent with posteriors from the macaque study.
6.3 Bayesian Computations
The two stage analysis ran MCMC chains 10,000 iterations with a burn-in of 3,000. The weighted ABC
analysis generated 10,000 accepted particles. Following standard practice [e.g., 1, 2, 19], the threshold
level  was set based on the discrepancy value that separated the closest 5% of synthetic data sets to Yo,
using d(Y,Yo) =
∑
t∈OV (yV t − yoV t)2/s2V +
∑
t∈OM (yMt − yoMt)2/s2M , where sV and sM are the standard
deviations of the observed values yoV , yoM , respectively.
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6.4 Some Posterior Summaries for Parameters
Figure 3 summarizes marginal posteriors from analysis of data on one macaque; these are typical of all 8
analyses. Evidently, some concentrated heavily in small regions relative to the diffuse initial U(0, 1) priors;
e.g., see rate parameters β, α, ρ, δ and γ. Margins for the carrying capacity parameters, KV and KM are
also quite informative, while those for V0 and the delays τV , τM are more diffuse while still contrasting
somewhat with their uniform priors. Figure 4 shows summaries for selected bivariate margins, evidencing
some posterior dependencies between rate parameters in the posterior distribution.
Figure 3: Macaque 400: posterior margins for the 10 parameters as annotated.
6.5 Comparisons of Subjects and Vaccination Routes
Figure 5 provides marginal posterior summaries to compare across the 8 macaques. In general, there is
substantial learning for the rate parameters β, α, and ρ, and for the carrying capacity parameters, KV and
KM . The extent of learning is dependent on the conditions of the experiment, evidenced by the varying
widths of credible intervals. For three parameter – the initial viral level V0 and delays τV , τM– such sparse
time series data is generally relatively uninformative: posteriors resemble priors on these quantities.
Color coding relates to immunization route of the vaccine administered– intra-nasal/intra-tracheal,
intra-rectal, or intra-vaginal. For ρ,KM , there is some indication of differences by immunization route,
which was unanticipated. Additional experiments directed towards comparing finer-scale immune re-
sponses across immunization route are suggested as a result.
6.6 MCMC+ABC Improves Predictive Model Fit
Posterior predictions assess and compare model fits; these demonstrate the positive benefit of the ABC
procedure in refining the first stage MCMC analysis. For each data set, final posterior parameter samples
9
Figure 4: Macaque 400: bivariate posterior margins for the 10 parameters as annotated.
Figure 5: Marginal posterior means and 90% credible intervals for key parameters on all 8 macaques.
Color reflects vaccine immunization route: intra-nasal/intra-tracheal (blue), intra-rectal (red), intra-vagina
(green).
were used to generate synthetic latent state trajectories. Figures 6 shows aspects of these predictions for
macaque #400. These posterior predictive trajectories were simulated (i) based on the first stage MCMC
alone, and (ii) from the full MCMC+ABC analysis. This shows that the MCMC analysis results in a relatively
good concordance with the data; however, systematic bias in overestimating the latent states is clear– likely
a result of linearization and lack of truncation in the MCMC analysis. The figure shows how the ABC step
10
is able to “correct” this, resulting in clear improvements in predictive fit.
Repeating this comparative analysis for the other 6 data sets leads to similar conclusions; see graphs
in the Supplementary Material. For some cases, very clear improvements are evident. For a few, such as
macaque #401, there is less evidence of systematic bias in the MCMC analysis, and then the ABC step
results in minimal adjustment.
Figure 6: Posterior predictions for macaque #400: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
6.7 Comparisons via Dimensionless Model Parameters
The dimensionless form of equation (2) is a “canonical skeleton” of the non-linear model. We can compare
across experiments in terms of (i) the dimensionless parameters η = αβ/(KVKM ) and ψ = ρKV /β, and
(ii) the transformed time scale s = βt. Also, from Section 4.1, the implied transformed time delays are
λV = βτV and λM = βτM . Figure 5 already shows major differences across macaques in the posteriors for
β, indicating substantial differences in effective time scales of immune responses across subjects. For the
other dimensionless parameters, we simply transform the MCMC+ABC posterior samples to approximate
posteriors for (η, ψ, λV , λM ) to study what has been learned about these “canonical” parameters and how
they compare across subjects. Figures 7,8,9 show marginal and bivariate posteriors for macaque #400,
and credible interval summaries for these 4 quantities on all 8 macaques; the latter shows up evident
differences across macaques, especially for η, ψ.
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Figure 7: Macaque 400: posterior margins for the for the dimensionless model parameters as annotated.
Figure 8: Macaque 400: bivariate posterior margins for the dimensionless model parameters as annotated.
Figure 9: Marginal posterior means and 90% credible intervals for dimensionless model parameters on
all 8 macaques. Color reflects vaccine immunization route: intra-nasal/intra-tracheal (blue), intra-rectal
(red), intra-vagina (green).
6.8 Learnability of Model Parameters
To quantify and analyze the extent of learning about each parameter, we evaluate two indices based on
the marginal posterior samples for each. The first index is the entropy (H) of the posterior relative to
the prior, computed based on a binned representation of the posterior and prior distributions. The second
index is the log ratio of marginal posterior to prior standard deviations. We transformed parameters
having non-uniform priors (i.e., parameters KV ,KM , η, ψ, λV , λM ) before computing these indices; the
transformations were based on inverse prior cdfs so that the indices compare posteriors to uniform priors.
Figure 10 shows an illustrative example of these “learnability indices” for macaque #400; those for
other macaques are comparable and can be found in the Supplementary material. There is limited data-
12
Figure 10: Macaque 400: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
based information about the three parameters (V0, τM , τV ), very much more significant information about
parameters (γ, δ,KV , α, ρ), with the others in-between. There is similarly variation in the degrees of “learn-
ability” of the dimensionless parameters, evident in Figure 10. While η, ψ appear less learnable than others
for macaque #400, their posterior SDs are smaller than prior SDs by at least a factor of 2, and in the case
of η it is almost a factor of 5, so that data information on these two parameters– earlier noted as reflecting
substantial differences across macaques– is appreciable.
7 Additional Comments
The HIV/SIV immune vaccine study exemplifies emerging studies that aim to evaluate and compare ef-
ficacies of candidate vaccine designs in terms of resulting dynamic immune responses. As experimental
techniques develop, we will see larger such experiments– in human subjects as well as NHPs– with time
series data at a higher level of time resolution. The models developed here represent key aspects of pro-
gression of viral and memory cells, with time delays and stochastic elements that are evidently relevant.
The constrained model form allows us to identify information in even this very sparse data about some of
the model parameters, including differences across subjects in key rate (β) and maximum level (KV ,KM )
parameters that relate to critical aspects of the response profile. We also capture meaningful levels of
between-subject variability that are likely to be even more relevant in future human studies.
Fitting non-linear dynamic models– with inherently long series of latent states to be inferred, along
with multiple parameters– based on sparse time series data is an outstanding research challenge in com-
putational statistics. After detailed development and evaluation of a range of MCMC and sequential Monte
Carlo techniques, we have defined a direct coupling of analytic approximation-based MCMC with an ABC
strategy that appears quite effective in Bayesian calibration of our model. Biases inherent in the MCMC
analysis based on analytic approximations can be corrected by a second stage ABC processing of MCMC
outputs, while cases with little or no bias remain relatively unchanged. Bayesian analysis naturally and
gracefully handles the sparsity of data relative to a high-dimensional latent state and model parameters:
posterior distributions appear similar to priors for parameters that are not learnable, while uncertainties
in posteriors for other parameters and latent states capture and quantify the extent of information rele-
vant to those aspects. Evidently, the overall strategy– though developed for this applied study– could be
generalized in various ways as well as used directly in other applications of non-linear dynamic models.
The HIV/SIV vaccination study exhibits this selective learning about model parameters. Marginal pos-
teriors for some parameters are highly concentrated relative to the priors, whereas for others the posterior
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is relatively similar to the prior. The inclusion of a time delay is a key model component, and all non-
dimensional parameters are learnable. Interestingly, the results raise suggestions that the dynamics of the
immune response depends on the vaccination route. This is not obvious from inspection of the time series
data alone, and suggests follow-on experiments. With additional experimental data coming on stream, we
are now in a position to address future analyses with perhaps more informative priors that build on the
results here. One other area for further development is to consider hierarchical models that link parame-
ters of models in a given immunization route group via a second stage prior, and even, perhaps, then add
a further hierarchical component to link hyper-parameters across route groups. This would enable and
encourage– when relevant– information sharing that could be beneficial, especially in contexts like this
where data on each subject is sparse. Such developments, while beyond the scope of this paper, are under
study.
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Supplementary Material: Additional Figures
This supplement includes the additional graphical summaries of posteriors from the analysis of all 8
macaques, together with the raw time series data.
Figure 11: Observed data Vt (blue) and Mt (red) for all 8 macaques (subject IDs 400, 401, 404, 405, 407,
408, 415 and 431, respectively, from top left running left-to-right then down the rows).
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Figure 12: Synthetic trajectories of of Vt (blue) and Mt (red) from the initial ODE model based on forward
integration, using (V0,M0) = (0.5, 0.5) as initial values. The four outcomes of the model are based on the
parameters{β,KV , α, ρ,KM} given by (0.05, 30, 0.001, 0.001, 5), (0.05, 50, 0.001, 0.0001, 10), (0.02,
80, 0.001, 0.05, 4), and (0.02, 80, 0.005, 0.0001, 6).
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Figure 13: Synthetic trajectories of Vt (blue) and Mt (red) from the discrete-time, non-linear stochastic
model with time delays. These start at (V0,M0) = (0.5, 0.5) and use model parameters chosen to be
consistent with posteriors from the macaque study. The four outcomes (left to right, top down) are based
on the parameters {β, δ, α, ρ, γ, τV , τM , κ2V , κ2M} given by (0.05, 0.05/30, 0.001, 0.001, 0.001/5, 5, 30,
0.025, 0.005), (0.05, 0.05/50, 0.001, 0.0001, 0.0001/10, 20, 5, 0.05, 0.01), (0.02, 0.02/80, 0.001, 0.05,
0.05/4, 10, 30, 0.1, 0.01), and (0.02, 0.02/80, 0.005, 0.0001, 0.0001/6, 20, 20, 0.2, 0.05).
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Figure 14: Marginal posterior means and 90% credible intervals for the full set of model parameters on
all 8 macaques. Color reflects vaccine immunization route: intra-nasal/intra-tracheal (blue), intra-rectal
(red), intra-vagina (green).
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Figure 15: Posterior predictions for macaque #400: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 16: Posterior predictions for macaque #401: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 17: Posterior predictions for macaque #404: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 18: Posterior predictions for macaque #405: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 19: Posterior predictions for macaque #407: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 20: Posterior predictions for macaque #408: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 21: Posterior predictions for macaque #415: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 22: Posterior predictions for macaque #431: Top left: Observed data (blue); 50% (red), 95%
(magenta) credible bands and median (gray) of posterior predictions for the latent states using only MCMC
analysis. Top right: Same format, but based on MCMC+ABC analysis. Lower center: 100 sample trajectories
from the posterior predictive distribution of the latent states from MCMC+ABC analysis.
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Figure 23: Macaque 400: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
Figure 24: Macaque 400: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
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Figure 25: Macaque 404: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
Figure 26: Macaque 405: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
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Figure 27: Macaque 407: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
Figure 28: Macaque 408: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
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Figure 29: Macaque 415: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
Figure 30: Macaque 431: Learnability summaries. Posterior:prior relative entropy H against log of pos-
terior to prior standard deviation, in some cases implicitly based on parameters following inverse c.d.f.
transform to uniform priors as relevant.
32
